On this episode, Talk Radioisotopes hosts Scott Larrivee and Sarah Scouten sit down with Shaemus Gleason, Executive Vice President at Clarity Pharmaceuticals.
The discussion highlights Shaemus’s journey through the radiopharmaceutical industry, Clarity’s innovations, and breakthroughs involving copper-based compounds for cancer treatment.
Shaemus shares insights on the importance of chelators, supply chain logistics, and diagnostic imaging, emphasizing the need for universal patient access and the evolution of personalized medicine. The episode concludes with an optimistic outlook on the industry’s future and things on the horizon.
